A New Index Play on the Diet Drug Revolution

A new poll recently published by health policy research firm KFF revealed that roughly 12% of U.S. adults (or one in eight) have taken GLP-1 drugs, a category that includes Wegovy, Ozempic, Zepbound, and Mounjaro. Of those surveyed, 6% are currently taking a drug from that group. Although many survey participants rely on these medications [...] The post A New Index Play on the Diet Drug Revolution appeared first on ETF Trends .